Unknown

Dataset Information

0

Use of syngeneic cells expressing membrane-bound GM-CSF as an adjuvant to induce antibodies against native multi-pass transmembrane protein.


ABSTRACT: Membrane antigens (mAgs) are important targets for the development of antibody (Ab) drugs. However, native mAgs are not easily prepared, causing difficulties in acquiring functional Abs. In this study, we present a platform in which human mAgs were expressed in native form on cell adjuvants made with membrane-bound cytokines that were then used immunize syngeneic mice directly. The membrane-bound cytokines were used as immune stimulators to enhance specific Ab responses against the desired mAgs. Then, mAgs-expressing xenogeneic cells were used for Ab characterization to reduce non-specific binding. We established cell adjuvants by expressing membrane-bound cytokines (mIL-2, mIL-18, or mGM-CSF) on BALB/3T3 cells, which were effective in stimulating splenocyte proliferation in vitro. We then transiently expressed ecotropic viral integration site 2B (EVI2B) on the adjuvants and used them to directly immunize BALB/c mice. We found that 3T3/mGM-CSF cells stimulated higher specific anti-EVI2B Ab response in the immunized mice than the other cell adjuvants. A G-protein coupled receptor (GPCR), CXCR2, was then transiently expressed on 3T3/mGM-CSF cell adjuvant to immunize mice. The immune serum exhibited relatively higher binding to xenogeneic 293?A/CXCR2 cells than 293?A cells (~3.5-fold). Several hybridoma clones also exhibited selective binding to 293?A/CXCR2 cells. Therefore, the cell adjuvant could preserve the native conformation of mAgs and exhibit anti-mAg Ab stimulatory ability, providing a more convenient and effective method to generate functional Abs, thus possibly accelerating Ab drug development.

SUBMITTER: Huang CC 

PROVIDER: S-EPMC6616555 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Use of syngeneic cells expressing membrane-bound GM-CSF as an adjuvant to induce antibodies against native multi-pass transmembrane protein.

Huang Chien-Chiao CC   Cheng Kai-Wen KW   Hsieh Yuan-Chin YC   Lin Wen-Wei WW   Cheng Chiu-Min CM   Yuan Shyng-Shiou F SF   Chen I-Ju IJ   Cheng Yi-An YA   Lu Yun-Chi YC   Huang Bo-Cheng BC   Tung Yi-Ching YC   Cheng Tian-Lu TL  

Scientific reports 20190709 1


Membrane antigens (mAgs) are important targets for the development of antibody (Ab) drugs. However, native mAgs are not easily prepared, causing difficulties in acquiring functional Abs. In this study, we present a platform in which human mAgs were expressed in native form on cell adjuvants made with membrane-bound cytokines that were then used immunize syngeneic mice directly. The membrane-bound cytokines were used as immune stimulators to enhance specific Ab responses against the desired mAgs.  ...[more]

Similar Datasets

| S-EPMC3922726 | biostudies-literature
| S-EPMC4385005 | biostudies-literature
| S-EPMC8034741 | biostudies-literature
| S-EPMC4506079 | biostudies-literature
| S-EPMC4255968 | biostudies-literature
| S-EPMC7037240 | biostudies-literature
| S-EPMC4770717 | biostudies-literature
| S-EPMC9850113 | biostudies-literature
| S-EPMC5352159 | biostudies-literature
| S-EPMC6350682 | biostudies-literature